uniQure (QURE) Stock Forecast & Price Target

Compare

1,317 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

QURE Analyst Ratings

Strong Buy

11 Buy

1 Hold

0 Sell

Based on 12 analysts giving stock ratings to

uniQure

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

QURE Stock 12 Month Forecast

Average Price Target

$75.50

▲(25.90% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for uniQure in the last 3 months. The average price target is $75.50 with a high forecast of $110.00 and a low forecast of $56.00. The average price target represents a 25.90% change from the last price of $59.97.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3":"$3","30":"$30","57":"$57","84":"$84","111":"$111"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":110,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$110.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":75.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$75.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":56,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$56.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3,30,57,84,111],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,54.99,59.221538461538465,63.45307692307692,67.68461538461538,71.91615384615385,76.14769230769231,80.37923076923077,84.61076923076922,88.84230769230768,93.07384615384615,97.30538461538461,101.53692307692307,105.76846153846154,{"y":110,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,54.99,56.56769230769231,58.145384615384614,59.723076923076924,61.300769230769234,62.878461538461536,64.45615384615385,66.03384615384616,67.61153846153846,69.18923076923078,70.76692307692308,72.34461538461538,73.9223076923077,{"y":75.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,54.99,55.06769230769231,55.145384615384614,55.223076923076924,55.300769230769234,55.378461538461536,55.456153846153846,55.533846153846156,55.611538461538466,55.68923076923077,55.76692307692308,55.84461538461539,55.92230769230769,{"y":56,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":4.62,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.86,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.13,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.66,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.74,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.15,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.91,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.48,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.99,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.7,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.01,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.99,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$110.00

Average Price Target$75.50

Lowest Price Target$56.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Luca Issi

RBC Capital

$55→$65

Buy

8.39%

Upside

Reiterated

10/08/25

RBC Capital Sticks to Their Buy Rating for uniQure (QURE)RBC Capital analyst Luca Issi raised the price target on uniQure BV (NASDAQ: QURE) to $65.00 (from $55.00) while maintaining a Outperform rating.

Patrick Trucchio

H.C. Wainwright

$70→$110

Buy

83.43%

Upside

Reiterated

10/06/25

uniQure's AMT-130: Promising Huntington's Disease Therapy with Strong Clinical Efficacy and Favorable Safety Profile

Yanan Zhu

Wells Fargo

$65→$80

Buy

33.40%

Upside

Reiterated

10/02/25

uniQure price target raised to $80 from $65 at Wells FargouniQure price target raised to $80 from $65 at Wells Fargo

Kristen Kluska

Cantor Fitzgerald

$47→$80

Buy

33.40%

Upside

Reiterated

09/25/25

uniQure price target raised to $80 from $47 at Cantor FitzgeralduniQure price target raised to $80 from $47 at Cantor Fitzgerald

Salveen Richter

Goldman Sachs

$13→$56

Hold

-6.62%

Downside

Reiterated

09/25/25

uniQure (QURE) Gets a Hold from Goldman Sachs

Daniil Gataulin

Chardan Capital

$35→$76

Buy

26.73%

Upside

Reiterated

09/25/25

uniQure (QURE) Gets a Buy from Chardan Capital

Sami Corwin

William Blair

―

Buy

―

Reiterated

09/24/25

uniQure's Promising Advancements in Huntington's Disease Treatment and Strong Financial Position Justify Buy Rating

Joseph Schwartz

Leerink Partners

$48→$68

Buy

13.39%

Upside

Reiterated

09/24/25

Leerink says uniQure stock could trade up 100% on HD study dataLeerink says uniQure stock could trade up 100% on HD study data

Joseph Thome

TD Cowen

―

Buy

―

Reiterated

09/24/25

uniQure (QURE) Receives a Buy from TD Cowen

Debjit Chattopadhyay

Guggenheim

$28→$95

Buy

58.41%

Upside

Reiterated

09/24/25

uniQure price target raised to $95 from $28 at GuggenheimuniQure price target raised to $95 from $28 at Guggenheim

Paul Matteis

Stifel Nicolaus

$30→$65

Buy

8.39%

Upside

Reiterated

09/24/25

Stifel Nicolaus Remains a Buy on uniQure (QURE)

Uy Ear

Mizuho Securities

$30→$60

Buy

0.05%

Upside

Reiterated

09/24/25

Mizuho Securities Reaffirms Their Buy Rating on uniQure (QURE)Given the highly positive data, we reiterate our OP and raise our DCF-derived PT from $30 to $60 (see Exhibit 1 for contributions).

Danielle Brill

Truist Financial

$9.12

Buy

-84.80%

Downside

Reiterated

12/10/24

uniQure upgraded to Strong Buy from Outperform at Raymond JamesuniQure upgraded to Strong Buy from Outperform at Raymond James

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Luca Issi

RBC Capital

$55→$65

Buy

8.39%

Upside

Reiterated

10/08/25

Patrick Trucchio

H.C. Wainwright

$70→$110

Buy

83.43%

Upside

Reiterated

10/06/25

uniQure's AMT-130: Promising Huntington's Disease Therapy with Strong Clinical Efficacy and Favorable Safety Profile

Yanan Zhu

Wells Fargo

$65→$80

Buy

33.40%

Upside

Reiterated

10/02/25

uniQure price target raised to $80 from $65 at Wells FargouniQure price target raised to $80 from $65 at Wells Fargo

Kristen Kluska

Cantor Fitzgerald

$47→$80

Buy

33.40%

Upside

Reiterated

09/25/25

uniQure price target raised to $80 from $47 at Cantor FitzgeralduniQure price target raised to $80 from $47 at Cantor Fitzgerald

Salveen Richter

Goldman Sachs

$13→$56

Hold

-6.62%

Downside

Reiterated

09/25/25

uniQure (QURE) Gets a Hold from Goldman Sachs

Daniil Gataulin

Chardan Capital

$35→$76

Buy

26.73%

Upside

Reiterated

09/25/25

uniQure (QURE) Gets a Buy from Chardan Capital

Sami Corwin

William Blair

―

Buy

―

Reiterated

09/24/25

uniQure's Promising Advancements in Huntington's Disease Treatment and Strong Financial Position Justify Buy Rating

Joseph Schwartz

Leerink Partners

$48→$68

Buy

13.39%

Upside

Reiterated

09/24/25

Leerink says uniQure stock could trade up 100% on HD study dataLeerink says uniQure stock could trade up 100% on HD study data

Joseph Thome

TD Cowen

―

Buy

―

Reiterated

09/24/25

uniQure (QURE) Receives a Buy from TD Cowen

Debjit Chattopadhyay

Guggenheim

$28→$95

Buy

58.41%

Upside

Reiterated

09/24/25

uniQure price target raised to $95 from $28 at GuggenheimuniQure price target raised to $95 from $28 at Guggenheim

Paul Matteis

Stifel Nicolaus

$30→$65

Buy

8.39%

Upside

Reiterated

09/24/25

Stifel Nicolaus Remains a Buy on uniQure (QURE)

Uy Ear

Mizuho Securities

$30→$60

Buy

0.05%

Upside

Reiterated

09/24/25

Mizuho Securities Reaffirms Their Buy Rating on uniQure (QURE)Given the highly positive data, we reiterate our OP and raise our DCF-derived PT from $30 to $60 (see Exhibit 1 for contributions).

Danielle Brill

Truist Financial

$9.12

Buy

-84.80%

Downside

Reiterated

12/10/24

uniQure upgraded to Strong Buy from Outperform at Raymond JamesuniQure upgraded to Strong Buy from Outperform at Raymond James

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering uniQure

1 Month

xxx

Success Rate

18/37 ratings generated profit

Average Return

+1.24%

reiterated a xxx

rating 16 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 48.65% of your transactions generating a profit, with an average return of +1.24% per trade.

3 Months

xxx

Success Rate

18/37 ratings generated profit

Average Return

+6.11%

reiterated a xxx

rating 16 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 48.65% of your transactions generating a profit, with an average return of +6.11% per trade.

1 Year

Patrick TrucchioH.C. Wainwright

Success Rate

17/24 ratings generated profit

Average Return

+153.68%

reiterated a buy rating 4 days ago

Copying Patrick Trucchio's trades and holding each position for 1 Year would result in 70.83% of your transactions generating a profit, with an average return of +153.68% per trade.

2 Years

xxx

Success Rate

20/24 ratings generated profit

Average Return

+393.81%

reiterated a xxx

rating 4 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 83.33% of your transactions generating a profit, with an average return of +393.81% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

QURE Analyst Recommendation Trends

Rating

Jun 25

Jul 25

Aug 25

Sep 25

Oct 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, QURE has received 22 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. QURE average Analyst price target in the past 3 months is 75.50.

Each month's total comprises the sum of three months' worth of ratings.

QURE Financial Forecast

QURE Earnings Forecast

Next quarter’s earnings estimate for QURE is -$0.91 with a range of -$1.06 to -$0.63. The previous quarter’s EPS was -$0.69. QURE beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year QURE has Preformed in-line its overall industry.

QURE Sales Forecast

Next quarter’s sales forecast for QURE is $5.31M with a range of $0.00 to $9.65M. The previous quarter’s sales results were $5.26M. QURE beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year QURE has Preformed in-line its overall industry.

QURE Stock Forecast FAQ

What is QURE’s average 12-month price target, according to analysts?

Based on analyst ratings, uniQure N.V.’s 12-month average price target is 75.50.

What is QURE’s upside potential, based on the analysts’ average price target?

uniQure N.V. has 25.90% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is QURE a Buy, Sell or Hold?

uniQure N.V. has a consensus rating of Strong Buy which is based on 11 buy ratings, 1 hold ratings and 0 sell ratings.

What is uniQure N.V.’s price target?

The average price target for uniQure N.V. is 75.50. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $110.00 ,the lowest forecast is $56.00. The average price target represents 25.90% Increase from the current price of $59.97.

What do analysts say about uniQure N.V.?

uniQure N.V.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of QURE?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

uniQure (QURE) Stock Forecast & Price Target

QURE Analyst Ratings

QURE Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering uniQure

QURE Analyst Recommendation Trends

QURE Financial Forecast

QURE Earnings Forecast

QURE Sales Forecast

QURE Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts